# EDGAR Filing Document

**Accession Number:** 0001871321
**File Stem:** 0001213900-26-025239
**Filing Date:** 2026-3
**Character Count:** 16706
**Document Hash:** 8c091d587489691d823b8a12713c7140
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-26-025239.hdr.sgml**: 20260309

**ACCESSION NUMBER**: 0001213900-26-025239

**CONFORMED SUBMISSION TYPE**: S-8

**PUBLIC DOCUMENT COUNT**: 16

**FILED AS OF DATE**: 20260309

**DATE AS OF CHANGE**: 20260309

**EFFECTIVENESS DATE**: 20260309

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Alpha Tau Medical Ltd.
- **CENTRAL INDEX KEY:** 0001871321
- **STANDARD INDUSTRIAL CLASSIFICATION:** SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 000000000
- **STATE OF INCORPORATION:** L3
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** S-8
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 333-294151
- **FILM NUMBER:** 26735978

**BUSINESS ADDRESS:**
- **STREET 1:** KIRYAT HAMADA 5
- **CITY:** JERUSALEM
- **STATE:** L3
- **ZIP:** 9777605
- **BUSINESS PHONE:** 972-3-577-4115

**MAIL ADDRESS:**
- **STREET 1:** KIRYAT HAMADA 5
- **CITY:** JERUSALEM
- **STATE:** L3
- **ZIP:** 9777605

**As filed with the Securities and Exchange Commission on March 9, 2026**

**Registration No. 333-**

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM S-8**

**REGISTRATION STATEMENT**

***UNDER***

***THE SECURITIES ACT OF 1933***

**ALPHA TAU MEDICAL LTD.**

**(Exact name of Registrant as specified in its charter)**

---

| | |
|:---|:---|
| **State of Israel** | **Not applicable** |
| **(State or other jurisdiction of**<br> **incorporation or organization)**<br>**Kiryat HaMada St. 5**<br> **Jerusalem, Israel** | **(I.R.S. Employer**<br> **Identification No.)**<br>**9777605** |
| **(Address of Principal Executive Offices)** | **(Zip Code)** |

---

**Alpha Tau Medical Ltd. 2021 Share Incentive Plan**

**Alpha Tau Medical Ltd. 2021 Employee Share Purchase Plan**

**(Full Title of the Plan)**

**Alpha Tau Medical, Inc.**

**1 Union Street 3<sup>rd</sup> Floor**

**Lawrence, MA 01840<br> (833) 455-3278** 

**(Name, address, including zip code, and telephone number, including area code, of agent for service)**

***Copies to:***

---

| | |
|:---|:---|
| **Joshua G. Kiernan**<br> **Latham & Watkins LLP**<br> **1271 Avenue of the Americas**<br> **New York, New York 10020**<br> **Tel: (212) 906-1200** | **Shachar Hadar<br> Matthew Rudolph**<br> **Meitar \| Law Offices**<br> **16 Abba Hillel Silver Rd.**<br> **Ramat Gan 52506, Israel**<br> **Tel: (+972) (3) 610-3100** |

---

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐ Accelerated filer ☒ <br> Non-accelerated filer ☐ Smaller reporting company ☐ <br> Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

**EXPLANATORY NOTE**

Pursuant to General Instruction E of Form S-8, Alpha Tau Medical Ltd. (the "Registrant," "we" or "our") is filing this Registration Statement with the Securities and Exchange Commission (the "SEC") to register (i) 3,520,289 additional ordinary shares, no par value ("Ordinary Shares"), of the Registrant reserved for issuance under the Alpha Tau Medical Ltd. 2021 Share Incentive Plan (the "2021 Plan") resulting from an automatic annual increase as of January 1, 2026 and (ii) 880,097 additional Ordinary Shares reserved for issuance under the Alpha Tau Medical Ltd. 2021 Employee Share Purchase Plan (the "ESPP") resulting from an automatic annual increase as of January 1, 2026. Registration Statements of the Registrant on Form S-8 relating to the 2021 Plan and ESPP are effective.

**INCORPORATION BY REFERENCE OF CONTENTS OF REGISTRATION STATEMENT** 

**ON FORM S-8**

Except as set forth below, the contents of the Registration Statements on Form S-8 (File Nos. [333-264169](http://www.sec.gov/Archives/edgar/data/1871321/000110465922043414/tm229943d2_s8.htm), [333-270406](http://www.sec.gov/Archives/edgar/data/1871321/000121390023018900/ea174831-s8_alphatau.htm), [333-277733](http://www.sec.gov/Archives/edgar/data/1871321/000121390024020783/ea0201210-s8_alphatau.htm) and [333-285745](http://www.sec.gov/Archives/edgar/data/1871321/000121390025023243/ea0233726-s8_alphatau.htm)), filed with the Securities and Exchange Commission, relating to the 2021 Plan and the ESPP, are incorporated herein by reference.

**Item 8. Exhibits.**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Incorporation by Reference** | **Incorporation by Reference** | **Incorporation by Reference** | **Incorporation by Reference** | **Incorporation by Reference** | |
| **Exhibit No.** | **Description** | **Form** | **File No.** | **Exhibit No.** |<br>**Filing Date** |
| 4.1 | [Amended and Restated Articles of Association of Alpha Tau Medical Ltd.](https://www.sec.gov/Archives/edgar/data/0001871321/000110465922038887/drts-20211231xex1d1.htm) | 20-F | 001-41316 | 1.1 | March 9, 2023 |
| 4.2 | [Specimen Ordinary Share Certificate](http://www.sec.gov/Archives/edgar/data/1871321/000119312522002633/d199994dex45.htm) | F-4 | 333-258915 | 4.5 | January 5, 2022 |
| 5.1 | [Opinion of Meitar \\| Law Offices.](ea028037701ex5-1.htm) |  |  |  | \* |
| 23.1 | [Consent of Kost, Forer, Gabbay & Kasierer, a member of Ernst & Young Global, independent registered accounting firm](ea028037701ex23-1.htm) |  |  |  | \* |
| 23.2 | [Consent of Meitar \\| Law Offices (included in Exhibit 5.1).](ea028037701ex23-1.htm) |  |  |  | \* |
| 24.1 | [Power of Attorney (included on the signature page of the Registration Statement).](#a_001) |  |  |  | \* |
| 99.1 | [2021 Share Incentive Plan of Alpha Tau Medical Ltd.](https://www.sec.gov/Archives/edgar/data/1871321/000119312521345535/d199994dex108.htm) | F-4 | 333-258915 | 10.8 | December 1, 2021 |
| 99.2 | [2021 Employee Share Purchase Plan of Alpha Tau Medical](https://www.sec.gov/Archives/edgar/data/1871321/000119312521345535/d199994dex109.htm) | F-4 | 333-258915 | 10.9 | December 1, 2021 |
| 107 | [Filing Fee Table](ea028037701ex-fee.htm) |  |  |  | \* |

---

**SIGNATURES**

Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Jerusalem, Israel, on March 9, 2026.

---

| | | |
|:---|:---|:---|
| **ALPHA TAU MEDICAL LTD.** | **ALPHA TAU MEDICAL LTD.** | **ALPHA TAU MEDICAL LTD.** |
| By: | */s/ Uzi Sofer* | */s/ Uzi Sofer* |
|  | Name:  | Uzi Sofer<br>|
|  | Title: | Chief Executive Officer |

---

**POWER OF ATTORNEY**

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below hereby constitutes and appoints Uzi Sofer and Raphi Levy, and each of them, individually, as his or her true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, for him or her and in his or her name, place and stead in any and all capacities, in connection with this Registration Statement, including to sign in the name and on behalf of the undersigned, this Registration Statement and any and all amendments thereto, including post-effective amendments and registrations filed pursuant to Rule 462 under the Securities Act of 1933, as amended, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents full power and authority to do and perform each and every act and thing requisite and desirable to be done in and about the premises, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or his or her substitute, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act of 1933, as amended, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated:

---

| | | |
|:---|:---|:---|
| **Signature** | **Title** | **Date** |
| /s/ Uzi Sofer | Chief Executive Officer & Chairperson | March 9, 2026 |
| Uzi Sofer | (Principal Executive Officer) |  |
| /s/ Raphi Levy | Chief Financial Officer | March 9, 2026 |
| Raphi Levy | (Principal Financial Officer and Principal Accounting Officer) |  |
| /s/ Ruth Alon | Director | March 9, 2026 |
| Ruth Alon |  |  |
| /s/ Michael Avruch | Director | March 9, 2026 |
| Michael Avruch |  |  |
| /s/ S. Morry Blumenfeld, Ph.D. | Director | March 9, 2026 |
| S. Morry Blumenfeld, Ph.D. |  |  |
| /s/ Maya Netser | Director | March 9, 2026 |
| Maya Netser |  |  |
| /s/ Alan Adler | Director | March 9, 2026 |
| Alan Adler |  |  |
| /s/ David Milch | Director | March 9, 2026 |
| David Milch<br>|  |  |
| /s/ Nadav Kidron | Director | March 9, 2026 |
| Nadav Kidron |  |  |

---

**AUTHORIZED REPRESENTATIVE**

Pursuant to the requirements of the Securities Act of 1933, the undersigned, the duly authorized representative in the United States of Alpha Tau Medical Ltd. has signed this registration statement on Form S-8 on March 9, 2026.

---

| | |
|:---|:---|
| **ALPHA TAU MEDICAL INC.** | **ALPHA TAU MEDICAL INC.** |
| By: | /s/ Uzi Sofer |
| Name: | Uzi Sofer |
| Title: | President and Director |

---

## Exhibit 5.1

**Exhibit 5.1**

![](ea028037701_ex5-1img1.jpg)

March 9, 2026

Alpha Tau Medical Ltd.<br> Kiryat HaMada St. 5<br> Jerusalem, Israel

**RE: <u>Registration on Form S-8</u>**

Ladies and Gentlemen:

We have acted as Israeli counsel to Alpha Tau Medical Ltd., an Israeli company (the "**Company**"), in connection with its filing of a registration statement on Form S-8 on or about March 9, 2026 (the "**Registration Statement**"), under the Securities Act of 1933, as amended (the "**Securities Act**"), relating to the registration of (i) 3,520,289 additional ordinary shares, no par value ("**Ordinary Shares**"), of the Company reserved for issuance under the Alpha Tau Medical Ltd. 2021 Share Incentive Plan (the "**2021 Plan**") resulting from an automatic annual increase as of January 1, 2026 and (ii) 880,097 additional Ordinary Shares reserved for issuance under the Alpha Tau Medical Ltd. 2021 Employee Share Purchase Plan (the "**ESPP**" and collectively the "**Plans**") resulting from an automatic annual increase as of January 1, 2026.

In our capacity as counsel to the Company, we have examined originals or copies, certified or otherwise identified to our satisfaction, of the Company's (i) amended and restated articles of association (the "**Articles**"), (ii) the Plans, (iii) resolutions of the Company's board of directors and (iv) other statements of corporate officers and other representatives of the Company and other documents provided to us by the Company as we have deemed necessary or appropriate as a basis for this opinion. In such examination, we have assumed the genuineness of all signatures, the legal capacity of natural persons, the authenticity of all documents submitted to us as originals and the conformity with the original documents of all documents submitted to us as copies or facsimiles. As to any facts material to this opinion, to the extent that we did not independently establish relevant facts, we have relied on certificates of public officials and certificates of officers or other representatives of the Company. We have also assumed the truth of all facts communicated to us by the Company and that all consents, minutes and protocols of meetings of the Company's board of directors, which have been provided to us, are true and accurate and prepared in accordance with the Articles and all applicable laws. In addition, we have assumed that the Company will receive the full consideration for the Ordinary Shares (which may consist, in part or in full, of services performed for the Company).

We are admitted to practice law in the State of Israel and the opinion expressed herein is expressly limited to the laws of the State of Israel.

On the basis of the foregoing, we are of the opinion that the Ordinary Shares being registered pursuant to the Registration Statement, when issued and paid for in accordance with the respective Plan, pursuant to agreements with respect to the respective Plan and, as the case may be, pursuant to the terms of the awards that have been or may be granted under the respective Plan, will be validly issued, fully paid and non-assessable.

![](ea028037701_ex5-1img2.jpg)

We hereby consent to the filing of this opinion as an exhibit to the Registration Statement. In giving this opinion and such consent, we do not admit that we are within the category of persons whose consent is required under Section 7 of the Securities Act, the rules and regulations of the Securities and Exchange Commission promulgated thereunder or Item 509 of Regulation S-K promulgated under the Securities Act.

This opinion letter is rendered as of the date hereof and we disclaim any obligation to advise you of facts, circumstances, events or developments that may be brought to our attention after the effective date of the Registration Statement that may alter, affect or modify the opinions expressed herein.

---

| |
|:---|
| Very truly yours, |
| /s/ Meitar \| Law Offices |

---

## Exhibit 23.1

**Exhibit 23.1**

**CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM**

We consent to the incorporation by reference in the Registration Statement (Form S-8) pertaining to the 2021 Share Incentive Plan and the 2021 Employee Share Purchase Plan of Alpha Tau Medical Ltd. of our report dated March 9, 2026, with respect to the consolidated financial statements of Alpha Tau Medical Ltd. included in its Annual Report (Form 20-F) for the year ended December 31, 2025, filed with the Securities and Exchange Commission.

---

| | |
|:---|:---|
| Tel Aviv, Israel | /s/ Kost Forer Gabbay & Kasierer |
| March 9, 2026 | A Member of EY Global |

---

## Ex-Filing

?xml version='1.0' encoding='ASCII'? Filing Fee Exhibit

**Ex-Filing Fees**

**CALCULATION OF FILING FEE TABLES**

**S-8**

**Alpha Tau Medical Ltd.**

**Table 1: Newly Registered Securities**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Security Type** | **Security Class Title** | **Notes** | **Fee Calculation<br> Rule** | **Amount Registered** | **Proposed Maximum Offering<br> Price Per Unit** | **Maximum Aggregate Offering Price** | **Fee Rate** | **Amount of Registration Fee** |
| Equity | Ordinary shares, no par value | (1) | 457(a) | 4400486 | $6.68 | $29395246.48 | 0.0001381 | $4059.49 |
| Total Offering Amounts: | Total Offering Amounts: | Total Offering Amounts: | Total Offering Amounts: | Total Offering Amounts: | Total Offering Amounts: | $29395246.48 |  | 4059.49 |
| Total Fee Offsets: | Total Fee Offsets: | Total Fee Offsets: | Total Fee Offsets: | Total Fee Offsets: | Total Fee Offsets: |  |  | 0.00 |
| Net Fee Due: | Net Fee Due: | Net Fee Due: | Net Fee Due: | Net Fee Due: | Net Fee Due: |  |  | $4059.49 |

---

**__________________________________________ Offering Note(s)**

&nbsp;&nbsp;&nbsp;&nbsp;(1) In accordance with Rule 416 under the Securities Act of 1933, as amended, this registration statement shall be deemed to cover any additional securities that may from time to time be offered or issued to prevent dilution resulting from stock splits, stock dividends or similar transactions. Consists of an additional 3,520,389 shares of ordinary shares no par value ("Ordinary Shares") issuable under the Alphau Tau Medical Ltd. 2021 Share Incentive Plan (the "2021 Plan") pursuant to the terms of the 2021 Plan and an additional 880,097 shares of Ordinary Shares issuable under the Alpha Tau Medical Ltd. 2021 Employee Share Purchase Plan (the "ESPP") pursuant to the terms of the ESPP. Estimated solely for the purpose of calculating the registration fee pursuant to Rules 457(c) and 457(h) of the Securities Act of 1933, as amended, and based upon the average of the high and low prices of Alpha Tau Medical Ltd.'s (the "Registrant") ordinary shares as reported on The Nasdaq Global Select Market on March 4, 2026. The Registrant does not have any fee offsets.